Purification and characterization of natural and recombinant human plasminogen activator inhibitor‐1 (PAI‐1)
Open Access
- 31 July 1988
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 175 (3) , 531-540
- https://doi.org/10.1111/j.1432-1033.1988.tb14225.x
Abstract
Human plasminogen activator inhibitor‐1 (PAI‐1) was purified from the conditioned medium of endotoxin‐stimulated umbilical vein endothelial cell cultures by combinations of zinc‐chelate‐Sepharose chromatography, gel filtration on Sephacryl S‐300 and immunoadsorption on an insolubilized murine monoclonal antibody (MA‐7D4). The final product was obtained with a recovery of approximately 20% from conditioned medium containing about 3 μ;g/ml PAI‐1. The yield of PAI‐1 was 15 – 100 μ;g/umbilical cord, depending on the culture and harvest conditions. SDS gel electrophoresis revealed a main band with Mr= 46000 both under reducing and non‐reducing conditions. On gel filtration on Sephacryl S‐300, however, the material was separated in two fractions, one eluting at the void volume, which contains active PAI‐1, and one with Mr= 46000 containing inactive material that could be reactivated with 12 M urea. SDS gel electrophoresis of the isolated high‐Mr fraction revealed several bands including a main 46000‐Mr component, which reacted with anti‐(PAI‐1) antibodies on immunoblotting and neutralized tissue‐type plasminogen activator (t‐PA). The active high‐Mr fraction and the reactivated low‐Mr fraction of PAI‐1 inhibited t‐PA very rapidly with an apparent second‐order rate constant of (1.5–4) × 107 M−1 S−1. The cDNA of endothelial cell PAI‐1 was cloned and expressed in Chinese hamster ovary cells. The translation product, purified from conditioned medium of transfected cells, also revealed a high‐Mr and a low‐Mr fraction on gel filtration, which were indistinguishable from the natural proteins by physicochemical, immunochemical and functional analysis. On reduced SDS gel electrophoresis, the high‐Mr fraction was separated into the Mr‐46000 low‐Mr PAI‐1 and two other components with Mr 65000 and one barely entering the gel. When reactivated low‐Mr PAI‐1 was added to plasma, PAI activity and PAI‐1 antigen eluted with an apparent Mr 300000 on gel filtration, indicating that active PAI‐1 complexes with one or more binding proteins in plasma.This publication has 50 references indexed in Scilit:
- Plasminogen activator inhibitor type‐1 : reactive center and amino‐terminal heterogeneity determined by protein and cDNA sequencingFEBS Letters, 1986
- Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.Journal of Clinical Investigation, 1986
- A Method for Isolation of Intact, Translationally Active Ribonucleic AcidDNA, 1983
- On the Rolw of the Carbohydrate Side Chains of Human Plasminogen in Its Interaction with α2‐Antiplasmin and FibrinEuropean Journal of Biochemistry, 1981
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Purification and Characterization of Human Antiplasmin, the Fast-Acting Plasmin Inhibitor in PlasmaEuropean Journal of Biochemistry, 1977
- Screening λgt Recombinant Clones by Hybridization to Single Plaques in SituScience, 1977
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Diffusion-in-Gel Methods for Immunological AnalysisPublished by S. Karger AG ,1958